Atlas Trials

Application of mRNA Immunotherapy Technology in Hepatitis B Virus-related Refractory Hepatocellular Carcinoma

Clinical trial NCT05738447 · UNKNOWN

Trial details

NCT number
NCT05738447
Sponsor
West China Hospital
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Liver CancerHepatocellular Carcinoma
Start date
2023-02-15
Primary completion
2024-01-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.